Discovery and optimization of 2,3-Dihydroindole derivatives as STING receptor allosteric agonists
Bioorganic & Medicinal Chemistry Letters · 2026
DOI: 10.1016/j.bmcl.2025.130508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026. Verfasst von Ying Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), Shandong Key Laboratory of Druggability Optimization a…. Hauptthemen laut MEDLINE: Membrane Proteins, Indoles, Drug Discovery. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Taishan Scholar Foundation of Shandong Province, Shandong University.
Abstract (Originalsprache)
STING allosteric agonists targeting the cryptic pocket in the transmembrane domain (TMD) could overcome the limitations of membrane permeability and oligomerization instability that are inherent to conventional cGAMP mimetics. Although compounds such as C53 and NVS-STG2 have been reported as TMD-targeting agonists, their therapeutic potential is restricted by insufficient potency. In this work, compound LA24 was identified as a novel potent STING allosteric agonist through structure-based multilevel virtual screening combined with rational optimization. It exhibited an EC₅₀ value of 0.82 μM, being superior to that of the reference C53 (EC50 = 2.80 μM). Molecular modeling studies revealed that LA24 exhibited enhanced STING agonistic activity by forming hydrogen bonds with key transmembrane domain residues G114 and Y106, as well as π-π stacking interactions with H50. These findings suggested that LA24 holds promise as a novel lead compound for the development of STING-targeted immunomodulatory therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical Sciences, C…
- Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, Shandong Province, PR China.
- Department of Pediatrics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, 250012 Jinan, Shandong Province, PR China; Shandong Luye Pharmaceutical Co., Ltd, China. Electronic address: Luxurynini@163.com.
- Shandong Luye Pharmaceutical Co., Ltd, China. Electronic address: liulanyu@luye.com.
- Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, Shandong Province, PR China. Electronic address: zhaohuajun89@sdu.edu.cn.
Förderung
- Natural Science Foundation of Shandong Province
- Taishan Scholar Foundation of Shandong Province
- Shandong University
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Wu, J., Gao, N., Zheng, L., Zhang, W., Zhao, F., Meng, B., Liu, X., Liu, L., Zhao, H., & Kang, D. (2026). Discovery and optimization of 2,3-Dihydroindole derivatives as STING receptor allosteric agonists. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2025.130508
Vancouver
Liu Y, Wu J, Gao N, Zheng L, Zhang W, Zhao F, et al. Discovery and optimization of 2,3-Dihydroindole derivatives as STING receptor allosteric agonists. Bioorganic & Medicinal Chemistry Letters. 2026. doi:10.1016/j.bmcl.2025.130508
BibTeX
@article{Liu2026,
author = {Liu, Ying and Wu, Jing and Gao, Ni and Zheng, Lin and Zhang, Wenbo and Zhao, Fabao and Meng, Bairu and Liu, Xinyong and Liu, Lanyu and Zhao, Huajun and Kang, Dongwei},
title = {Discovery and optimization of 2,3-Dihydroindole derivatives as STING receptor allosteric agonists},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2026},
doi = {10.1016/j.bmcl.2025.130508}
}
EUVIMED